Influence of Preoperative Lipid-Lowering Therapy on Postoperative Outcome in Patients Undergoing Coronary Artery Bypass Grafting

American Journal of Cardiology

Volumn 99, Issue 6, 2007, Pages 785-789

  Powell, Brian D ^a   Bybee, Kevin A ^c   Valeti, Uma ^b   Thomas, Randal J ^a   Kopecky, Stephen L ^a   Mullany, Charles J ^a   Wright, R Scott ^a  

^a MAYO CLINIC   (United States)

^b St Paul Heart Clinic   (United States)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETIC PATIENT; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK; STATISTICAL SIGNIFICANCE; SURVIVAL; UNIVARIATE ANALYSIS;

AGED; ANTILIPEMIC AGENTS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MINNESOTA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33847748975     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.10.036     Document Type: Article

References (30)

1. Knatterud G.L., Rosenberg Y., Campeau L., Geller N.L., Hunninghake D.B., Forman M.A., Forrester J.S., Gobel F.L., Herd J.A., Hickey A., et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Circulation 102 (2000) 157-165
2. Frick M.H., Syvanne M., Nieminen M.S., Kauma H., Majahalme S., Virtanen V., Kesaniemi Y.A., Pasternack A., and Taskinen M.R. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation 96 (1997) 2137-2143
3. Cashin-Hemphill L., Mack W.J., Pogoda J.M., Sanmarco M.E., Azen S.P., and Blankenhorn D.H. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. JAMA 264 (1990) 3013-3017
4. Campeau L., Knatterud G.L., Domanski M., Hunninghake D.B., White C.W., Geller N.L., and Rosenberg Y. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts. N Eng J Med 336 (1997) 153-162
5. Pan W., Pintar T., Anton J., Lee V.V., Vaughn W.K., and Collard C.D. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 110 suppl (2004) II-45-II-49
6. Dontani M.I., Elnicki D.M., Jain A.C., and Gibson C.M. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 86 (2000) 1128-1130
7. Christenson J.T. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 15 (1999) 394-399
8. Clark L., Ikonomidis J., Crawford F., Crumbley A., Kratz J., Stroud M., Woolson R., Buruce J., Nicholas J., Lackland D., Zile M., and Spinale F. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg 131 (2006) 679-685
9. Callahan K.O., Katsimaglis G., Tepper M.R., Ryan J., Mosby C., Ioannidis J.P., and Danias P.G. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery. J Am Coll Cardiol 45 (2005) 336-342
10. Chello M., Carassiti M., Agro F., Mastroroberto P., Pugliese G., Colonna D., and Covino E. Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesthes 18 (2004) 605-609
11. O'Driscoll G., Green D., and Taylor R. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95 (1997) 1126-1131
12. Dupuis J., Tardif J.C., Cernacek P., and Theroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial. Circulation 99 (1999) 3227-3233
13. Bustos C., Hernandez-Presa M., Ortego M., Tunon J., Ortega L., Perez F., Diaz C., Hernandez G., and Edgido J. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 32 (1998) 2057-2064
14. Beigel Y., Fuchs J., Snir M., Green P., Lurie Y., and Djaldetti M. Lovastatin therapy in hypercholesterolemia: effect on fibrinogen, hemorheologic parameters, platelet activity, and red blood cell morphology. J Clin Pharmacol 31 (1991) 512-517
15. Brull D.J., Sanders J., Rumley A., Lowe G., Humphries S.E., and Montgomery H.E. Statin therapy and the acute inflammatory response after coronary artery bypass grafting. Am J Cardiol 88 (2001) 431-433
16. Albert M.A., Danielson E., Rifai N., and Ridker P.M. Effect of staatin therapy on C-reactive protein levels. The Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study. JAMA 286 (2001) 64-70
17. Ferguson T.B., Coombs L.P., and Peterson E.D. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 287 (2002) 2221-2227
18. Mangano D.T., and Group MSoPIR. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 (2002) 1309-1317
19. Collins R., Armitage J., Parish S., Sleight P., Peto R., and Group H.P.S. Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
20. Ikeda Y., Young L.H., and Lefer A.M. Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats. J Cardiovasc Pharm 41 (2003) 649-656
21. Lefer D.J., Scalia R., Jones S.P., Sharp B.R., Hoffmeyer M.R., Farvid A.R., Gibson M.F., and Lefer A.M. HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB J 15 (2001) 1454-1456
22. Wayman N.S., Ellis B.L., and Thiemermann C. Simvastatin reduces infarct size in a model of acute myocardial ischemia and reperfusion in the rat. Med Sci Monit 9 suppl (2003) BR155-BR159
23. Rendig S.V., Symons J.D., and Amsterdam E.A. Effects of statins on myocardial and coronary artery response to ischemia-reperfusion. Can J Phys Pharmacol 81 (2003) 1064-1071
24. Arntz H., Wunderlich W., Schnitzer L., Stern R., Fischer F., Agrawal R., Linderer T., and Schultheiss H.P. Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study. Zeitschr Kardiol 88 (1999) 582-590
25. Bybee K., Wright R., Williams B., Murphy J., Holmes Jr. D., and Kopecky S. Effect of concomitant or very early statin administration on in-hospital mortality and re-infarction rates in patients with acute myocardial infarction. Am J Cardiol 87 (2001) 771-774
26. Schwarzt G.G., Olsson A.G., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., Zeiher A., Chaitman B.R., Leslie S., and Stern T. Effects of atorvastatin on early recurrent ischemc events in acute coronary syndrome: the MIRACL study. JAMA 285 (2001) 1711-1718
27. Kayikcioglu M., Can L., Kultursay H., Payzin S., and Turkoglu C. Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty. Acta Cardiol 57 (2002) 295-302
28. Pasceri V., Patti G., Nusca A., Pristipino C., Richichi G., and Di Sciasco G. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA study. Circulation 110 (2004) 674-678
29. Ali I., and Buth K. Preoperative statin use and in-hospital outcomes following heart surgery in patients with unstable angina. Eur J Cardiothorac Surg 27 (2005) 1051-1056
30. Bybee K., Powell B., Valeti V., Rosales A., Kopecky S., Mullany C., and Wright R. Pre-operative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 112 suppl I (2005) I-286-I-292